Skip to content

EFFECT OF TRANSCUTANEOUS VERSUS PERCUTANEOUS TIBIAL NERVE STIMULATION ON OVER ACTIVE BLADDER IN POST MENOPAUSAL WOMEN

EFFECT OF TRANSCUTANEOUS VERSUS PERCUTANEOUS TIBIAL NERVE STIMULATION ON OVER ACTIVE BLADDER IN POST MENOPAUSAL WOMEN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201911868991836
Enrollment
70
Registered
2019-11-29
Start date
2019-11-26
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases

Interventions

Sponsors

Faculty of Physical Therapy Cairo University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • Post-menopausal women suffering from pure urge urinary incontinence. • Their age will range from 55-65 years old. • Their body mass index (BMI) will range from 25-29.9 kg/m2. • They will experience menopause at least for 3 years.

Exclusion criteria

Exclusion criteria: Post-menopausal women will be excluded if they had: • Urinary tract infection • Previous surgery for urinary incontinence • Upper motor neuron diseases • History of genito-urinary cancer • Previous pelvic irradiation • Pure stress urinary incontinence • Genital prolapse • Diabetes mellitus • Pace maker • Metal implantation.

Design outcomes

Primary

MeasureTime frame
3-Day Bladder diary. It will be used to record the number of voids and number of incontinent episodes per day for each woman in all groups ;Pad test. It will be used to confirm and quantify the urine leakage for each woman in all groups (A,B&C). It is a simple noninvasive inexpensive, and easy method to evaluate the effect of treatment modalities for incontinence. Long duration (24 to 48 hours) pad test will be used ;Urodynamic Investigation System. It will also be used to measure the volume at first desire to void, first sensation of bladder filling (1st SBF) during cystometry, and maximum bladder capacity (MBC).

Secondary

MeasureTime frame
Overactive Bladder questionnaire Short Form (OAB-q SF): It will be used to assess symptoms and health-related quality of life (HR-QOL) for each woman in all groups (A,B&C). It is a brief, self-administered patient-reported outcomes tool with two scales. It is internally consistent, valid, and responsive to treatment-related change.

Countries

Egypt

Contacts

Public ContactSALWA EL BADRY

Professor

elbadry_s@yahoo.com+201001412962

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026